Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)

NCT06690047 is registered in ClinicalTrials.gov with Bernstein Clinical Research Center as lead sponsor.

NCT NCT06690047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06690047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)
Lead sponsor
Bernstein Clinical Research Center
Phase
Phase 4
Overall status
Completed
Start date
August 14, 2018
Completion date
April 28, 2022
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema